Eton Pharmaceutcials
ETON
71 hedge funds and large institutions have $182M invested in Eton Pharmaceutcials in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 3 closing their positions.
5,619% more call options, than puts
Call options by funds: $3.95M | Put options by funds: $69K
800% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 3
203% more capital invested
Capital invested by funds: $60M → $182M (+$122M)
145% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 11
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
48% more funds holding
Funds holding: 48 → 71 (+23)
12.45% more ownership
Funds ownership: 38.7% → 51.15% (+12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$12.8M |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
+$3.87M |
| 3 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.52M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.45M |
| 5 |
Millennium Management
New York
|
+$1.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Acuitas Investments
Seattle,
Washington
|
-$4M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$1.01M |
| 3 |
WIM
Westside Investment Management
Santa Monica,
California
|
-$441K |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$337K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$146K |
ETON Hedge Fund Activity: Q4 2024 in Review
71 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q4 2024, worth a combined $182M — up 203% from $60M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new ETON positions and 3 closed out — a net gain of 24 holders — while 27 added to existing stakes and 11 trimmed.
The largest buyer was EcoR1 Capital, adding an estimated $12.8M. The largest seller was Acuitas Investments, cutting an estimated $4M.
- 71 institutional investors held Eton Pharmaceutcials (ETON) as of Q4 2024, up from 48 in Q3 2024.
- Funds reported $182M of Eton Pharmaceutcials stock for Q4 2024, up 203% quarter-over-quarter.
- 27 funds opened new Eton Pharmaceutcials positions in Q4 2024 and 3 closed out, a net change of +24 holders.
- The largest Eton Pharmaceutcials buyer in Q4 2024 was EcoR1 Capital, an estimated $12.8M added.
- The largest Eton Pharmaceutcials seller in Q4 2024 was Acuitas Investments, an estimated $4M sold.
Based on aggregated 13F filings for Q4 2024.